Science In Public
Science writers, communicators, media, training, and public relations
The Inspiring Australia family has gotten a bit bigger and noisier, with the launch of the new opinion and discussion website, No Funny Business.
This site was created by the Australian Science Communicators and ScienceRewired, with articles provided by Australian National Centre for the Public Awareness of Science at ANU, but it belongs to the science engagement community as a place to share views and ideas on how we do our jobs. So head on over and make your voice heard!
$25,000 Centenary Institute Lawrence Creative Prize goes to young Melbourne researcherOne of Australia’s most creative young medical researchers has won a $25,000 prize to help her develop her ideas on how diet could prevent stroke deaths.
Connie Wong thinks we may be able to prevent early deaths following stroke with a fibre-based diet. She initially used innovative microscope techniques to determine how stroke weakens the immune system. Now she is studying how it also induces leakiness in the gut wall, leading to infection and an upsurge in deaths. And the solution may well lie in diet.
[Read more…] about Using diet to cope with the aftermath of stroke
The winner of the Centenary Institute Lawrence Creative Prize will be announced at 6.30 pm, Tuesday 12 November 2013, at a reception hosted by UBS in Sydney.
There are three finalists. On Tuesday we will find out who is the overall winner of the $25,000 prize. The two runners-up will each receive $5,000.
[Read more…] about Keeping our best young bioscience brains in Australia
In this post are images and short profiles on the three 2013 Centenary Institute Lawrence Creative Prize finalists.
[Read more…] about Centenary Institute Lawrence Creative Prize – photos and short profiles
When enzyme inhibiting drugs to treat diabetes were being developed, Mark Gorrell warned that care was needed to ensure the drugs targeted a specific enzyme, leaving other members of the enzyme family unaffected.
Thankfully, his warning was heeded by drug companies.
Associate Professor Mark Gorrell and his team of liver researchers at Sydney’s Centenary Institute have now confirmed that the diabetes drugs and potential cancer therapies based on regulating the dipeptidyl peptidase (DPP) family of enzymes must be carefully targeted to avoid serious side effects such as skin and intestinal damage.
[Read more…] about Diabetes drugs must be precisely targeted
Australian molecular biologists led by researchers at Centenary have made a synthetic compound that appears to allow them to control the leakiness of blood vessels. The work could lead to effective new drug treatments for strokes and tumours. Spinoffs may include an ability to reduce the side-effects of chemotherapy and inflammation.
Their lead drug candidate, known as CD5-2, was developed with the assistance of Mirrx Therapeutics, a privately owned Danish biotechnology company. Today Centenary has signed an agreement to develop this and other potential drugs with Mirrx. The agreement was facilitated by Bio-Link Australia Pty Ltd.
In this month’s newsletter:
[Read more…] about Connecting Australian researchers to Europe and Japan: EMBL Australia in November
Photos from the Prime Minister’s Prizes for Science award ceremony. [Read more…] about 2013 Prime Minister’s Prizes for Science – photos
The Prime Minister’s Prizes for Science were presented by the Prime Minister assisted by the Hon Bob Baldwin, Parliamentary Secretary to the Minister for Industry at the Prize Dinner in the Great Hall of Parliament House on Wednesday 30 October.
More about the winners below.
Below are comments provided by science leaders in Australia. They may be used when reporting on the Prime Minister’s Prizes for Science.
[Read more…] about 2013 Prime Minister’s Science Prizes: responses from colleagues and experts
